Literature DB >> 6202820

Evidence of HLA-DR antigen biosynthesis by human keratinocytes in disease.

B Volc-Platzer, O Majdic, W Knapp, K Wolff, W Hinterberger, K Lechner, G Stingl.   

Abstract

As opposed to normal human skin where HLA-DR expression is restricted to the Langerhans cell (LC) population, HLA-DR, but not HLA-DS antigens can be readily detected on keratinocytes (KC) in certain disease states, i.e., cutaneous T cell lymphoma (CTCL), graft-vs-host disease (GVHD), and lichen planus (LP). To clarify the cellular origin of KC-bound HLA-DR antigens, we used a monoclonal antibody directed against determinants solely expressed on the cytoplasmic HLA-DR gamma chain (VIC-Y1) and observed that, by immunofluorescence, KC displaying HLA-DR alpha/beta complexes on their surface uniformly displayed cytoplasmic VIC-Y1 reactivity. In view of the crucial role of the gamma chain for HLA-DR biosynthesis, we conclude that HLA-DR antigens on KC are actively synthesized by these cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6202820      PMCID: PMC2187314          DOI: 10.1084/jem.159.6.1784

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  22 in total

Review 1.  Origin and function of epidermal Langerhans cells.

Authors:  G Stingl; K Tamaki; S I Katz
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

2.  A matrix approach to human class II histocompatibility antigens: reactions of four monoclonal antibodies with the products of nine haplotypes.

Authors:  F M Brodsky
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

3.  Two types of Ia-positive T cells. Synthesis and exchange of Ia antigens.

Authors:  D T Yu; J M McCune; S M Fu; R J Winchester; H G Kunkel
Journal:  J Exp Med       Date:  1980-08-01       Impact factor: 14.307

4.  The invariant chain of murine Ia antigens: its glycosylation, abundance and subcellular localization.

Authors:  E Sung; P P Jones
Journal:  Mol Immunol       Date:  1981-10       Impact factor: 4.407

5.  Reactivity of Langerhans cells with hybridoma antibody.

Authors:  E Fithian; P Kung; G Goldstein; M Rubenfeld; C Fenoglio; R Edelson
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

6.  Characterization of HLA-D-region antigens by two-dimensional gel electrophoresis. Molecular-genotyping.

Authors:  D J Charron; H O McDevitt
Journal:  J Exp Med       Date:  1980-08-01       Impact factor: 14.307

7.  Murine Ia and human DR antigens: homology of amino-terminal sequences.

Authors:  J P Allison; L E Walker; W A Russell; M A Pellegrino; S Ferrone; R A Reisfeld; J A Frelinger; J Silver
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

8.  Studies on human epidermal Langerhans cells. I. Allo-activating and antigen-presenting capacity.

Authors:  L R Braathen; E Thorsby
Journal:  Scand J Immunol       Date:  1980       Impact factor: 3.487

9.  HLA-DR antigens have polymorphic light chains and invariant heavy chains as assessed by lysine-containing tryptic peptide analysis.

Authors:  J F Kaufman; R L Andersen; J L Strominger
Journal:  J Exp Med       Date:  1980-08-01       Impact factor: 14.307

10.  Biochemical characterization of a second family of human Ia molecules, HLA-DS, equivalent to murine I-A subregion molecules.

Authors:  S M Goyert; J E Shively; J Silver
Journal:  J Exp Med       Date:  1982-08-01       Impact factor: 14.307

View more
  35 in total

Review 1.  Dynamic nature and function of epidermal Langerhans cells in vivo and in vitro: a review, with emphasis on human Langerhans cells.

Authors:  M B Teunissen
Journal:  Histochem J       Date:  1992-10

2.  Epidermal keratinocyte Ia expression, Langerhans cell hyperplasia and lymphocytic infiltration in skin lesions of leprosy.

Authors:  T H Rea; J Y Shen; R L Modlin
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

3.  Induction of HLA-DR antigen expression in human endometrial epithelial cells in vitro by recombinant gamma-interferon.

Authors:  S S Tabibzadeh; M A Gerber; P G Satyaswaroop
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

4.  MHC class II antigen expression in normal human epidermis.

Authors:  M M Carr; E McVittie; K Guy; D J Gawkrodger; J A Hunter
Journal:  Immunology       Date:  1986-10       Impact factor: 7.397

5.  MHC class II antigen expression in human vascular smooth muscle cells is induced by interferon-gamma and modulated by tumour necrosis factor and lymphotoxin.

Authors:  S Stemme; G Fager; G K Hansson
Journal:  Immunology       Date:  1990-02       Impact factor: 7.397

6.  MHC class II+ keratinocytes from IFN gamma-treated human skin activate T cells in the presence of staphylococcal superantigen despite UVB irradiation.

Authors:  L Skov; O Baadsgaard
Journal:  Arch Dermatol Res       Date:  1996-05       Impact factor: 3.017

7.  Nonimmune human cells can express MHC class II antigens in the absence of invariant chain--an immunohistological study on normal and chronically inflamed small intestine.

Authors:  F Momburg; K Koretz; A Von Herbay; P Möller
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

8.  Induction of Thy-1 antigen on murine keratinocytes.

Authors:  A Scheynius; L Klareskog; R Holmdahl; P Larsson
Journal:  Immunology       Date:  1986-03       Impact factor: 7.397

9.  Tumor necrosis factor-alpha inhibits cell proliferation and induces class II antigens and cell adhesion molecules in cultured normal human keratinocytes in vitro.

Authors:  M Detmar; C E Orfanos
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

10.  HLA-DR expression is associated with excellent prognosis in squamous cell carcinoma of the larynx.

Authors:  F Esteban; F Ruiz-Cabello; A Concha; M Pérez-Ayala; J A Sánchez-Rozas; F Garrido
Journal:  Clin Exp Metastasis       Date:  1990 Jul-Aug       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.